Real-time disaster intelligence, alerts, and response tools.
Tuesday, April 21, 2026
[ad_1] SOUTH SAN FRANCISCO, Calif., Sept. 22, 2024 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq:IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that the company plans to […]
[ad_1] Strengthens Deerfield’s award-winning marketing and communications leadership to deliver specialized solutions to clients at all stages of development and commercialization CONSHOHOCKEN, Pa., Sept. 18, 2024 /PRNewswire/ — Deerfield Group, one of the fastest-growing independent […]
[ad_1] PITTSBURGH, Sept. 17, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS, “Viatris” or the “Company”) announced today the early tender results of the previously announced cash tender offer (the “Maximum Tender Offer”) of its subsidiary […]
[ad_1] The competition in follicular lymphoma is rapidly intensifying, with three CAR-T therapies and three bispecific antibodies now approved for relapsed or refractory patients. As both classes of treatments expand, the battle for dominance in […]
[ad_1] TORL-1-23 Demonstrates Clinically Meaningful, Durable and Confirmed Responses with a Generally Manageable Safety Profile in Patients with Claudin 6 Positive (CLDN6+) Platinum-Resistant Ovarian Cancer Expansion Cohorts in Patients with Ovarian, Non-Small Cell Lung Cancer, […]
